Skip to main content
SpringerLink
Log in

Pooled analysis of empagliflozin vs placebo in clinical trials

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Schorling ON, et al. Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus. Advances in Therapy : 5 May 2020. Available from: URL: https://doi.org/10.1007/s12325-020-01329-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pooled analysis of empagliflozin vs placebo in clinical trials. Reactions Weekly 1804, 10 (2020). https://doi.org/10.1007/s40278-020-78439-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-78439-3

Search

Navigation